Ditchcarbon
  • Contact
  1. Organizations
  2. Caris Life Sciences
Public Profile
Medical Device Manufacturing
FR
updated 17 days ago

Caris Life Sciences

Company website

Caris Life Sciences, a leading player in the precision medicine industry, is headquartered in France and operates extensively across Europe and North America. Founded in 2008, the company has made significant strides in advancing cancer care through its innovative molecular profiling services. Caris Life Sciences offers a unique suite of products, including comprehensive genomic profiling and biomarker testing, which empower healthcare providers to tailor treatments to individual patients. Their commitment to precision medicine has positioned them as a trusted partner in oncology, with notable achievements in improving patient outcomes. With a focus on integrating advanced technologies and data analytics, Caris Life Sciences continues to set benchmarks in the industry, driving forward the future of personalised medicine.

DitchCarbon Score

How does Caris Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Caris Life Sciences's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

33%

Let us know if this data was useful to you

Caris Life Sciences's reported carbon emissions

In 2023, Caris Life Sciences reported a Scope 3 emissions intensity of approximately 0.00037 kg CO2e per € gross profit, reflecting their operational impact in relation to revenue. This figure represents a decrease from the previous year's Scope 3 emissions intensity of about 0.00049 kg CO2e per € gross profit in 2022. Currently, Caris Life Sciences does not disclose any Scope 1 or Scope 2 emissions data, nor do they have specific reduction targets or commitments outlined through initiatives such as the Science Based Targets initiative (SBTi). The absence of detailed emissions data suggests that the company may still be in the early stages of formalising its climate commitments. As of now, Caris Life Sciences has not cascaded any emissions data from a parent or related organisation, indicating that their reported figures are independent. The company continues to navigate its climate strategy within the broader context of the life sciences industry, which is increasingly focused on sustainability and reducing carbon footprints.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Caris Life Sciences's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Caris Life Sciences is in FR, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Caris Life Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Personal Genome Diagnostics Inc.

US
•
Research and development services (73)
Updated 24 days ago

C2I Genomics Inc.

US
•
Research and development services (73)
Updated 23 days ago

SOPHiA GENETICS SA

CH
•
Computer and related services (72)
Updated 4 days ago

Esoterix Genetic Laboratories, LLC

US
•
Research and development services (73)
Updated 14 days ago

Natera

US
•
Research and development services (73)
Updated 25 days ago

Bio Rad

US
•
Research and development services (73)
Updated 4 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy